Chinese pharmaceutical and biomanufacturing company
1 AI-extracted insight from 1 source — podcasts, YouTube channels, and X/Twitter accounts.
Based on 1 scored insight about CSPC Pharmaceutical Group Limited.
The 1 sources with the most insights about CSPC Pharmaceutical Group Limited on Kazuha.
AI-generated insights from podcasts, YouTube videos, and X posts — ordered by most recent.
Signed a major $18.5 billion pipeline and development agreement with AstraZeneca, benefiting from China's cost and speed advantages in drug innovation.
Signed a major $18.5 billion pipeline and development agreement with AstraZeneca, benefiting from China's cost and speed advantages in drug innovation.
Other assets that creators frequently mention in the same content as CSPC Pharmaceutical Group Limited.
The most active sources covering CSPC Pharmaceutical Group Limited (1093.HK) on Kazuha are @theprofgpod. Kazuha aggregates AI-extracted insights from podcasts, YouTube channels, and X/Twitter accounts.
Kazuha has indexed 1 AI-extracted insight about CSPC Pharmaceutical Group Limited (1093.HK) from 1 different source. New insights are added whenever a covered creator publishes a new podcast episode, video, or post.
Creators covering CSPC Pharmaceutical Group Limited (1093.HK) most frequently also discuss TCEHY, AZN, 0388.HK, PFE, BABA. See the "Discussed alongside" section above for full asset pages.